Question

Difficulty: EasyPharmacologic Interventions

A 42-year-old man presents to the primary care clinic for a follow-up visit regarding elevated blood pressure. Over the past three months, his blood pressure measurements have consistently ranged from 145/92 mmHg to 152/96 mmHg despite strict lifestyle modifications. His past medical history is significant for asthma, which is well-controlled with an as-needed albuterol inhaler. The physician decides to initiate pharmacologic antihypertensive therapy. Which of the following medications should be avoided in this patient due to the risk of exacerbating his underlying respiratory condition?

  1. PropranololAnswer
  2. B
    Lisinopril
  3. C
    Amlodipine
  4. D
    Hydrochlorothiazide
  5. E
    Losartan

Answer

Propranolol should be avoided because it is a non-selective beta-blocker that can trigger bronchospasm in asthmatic patients.
The correct answer is the non-selective beta-blocker. Non-selective beta-blockers inhibit both beta-1 receptors (primarily in the heart) and beta-2 receptors (found in bronchial smooth muscle). Blockade of beta-2 receptors leads to bronchoconstriction and increased airway resistance, which can precipitate a severe or even fatal asthma exacerbation in susceptible individuals. Therefore, they are explicitly contraindicated in patients with a history of asthma.

Step-by-Step Solution

1
Identify the patient's concurrent medical conditions.
The patient has a history of asthma.
Concurrent conditions often dictate which medications are safe or contraindicated.
2
Evaluate the mechanism of action of the proposed antihypertensive medications.
Propranolol is a non-selective beta-blocker, meaning it antagonizes both beta-1 and beta-2 receptors.
Understanding the mechanism of action helps identify potential adverse effects on other organ systems.
3
Determine the effect of the medication on the patient's concurrent condition.
Blockade of beta-2 receptors in the lungs by non-selective beta-blockers leads to bronchoconstriction, which can precipitate an asthma exacerbation.
This establishes the absolute contraindication for using non-selective beta-blockers in asthmatic patients.

Key Concept

Non-selective beta-blockers are contraindicated in patients with asthma due to the risk of inducing bronchoconstriction via beta-2 receptor blockade.
Rate this question